Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : The thread of life -- Ignore unavailable to you. Want to Upgrade?

To: sjemmeri who wrote (1094)	8/25/2006 5:21:18 PM
From: Mike McFarland	Respond to of 1336

Fun to see it moving up finally. DPII shareholders are getting a fair deal-- I think Amgen paid $25M for 10% of Infinity. It wasn't any dang fun being down 20% in dpii all that time--but waiting patiently rather than taking a loss seemed reasonable. When you don't know what to do, do nothing. I'd just have shot a toe off in some other biotech. Seems to have good prospects and good management. I have to say, I was suprised how many companies are into HSP inhibitors...that may explain why nobody has rushed into the shares. On the other hand, I wonder if it is trending up now finally because the vote is being counted and the deal is looking more certain.